J Korean Med Sci.  2005 Dec;20(6):1053-1058. 10.3346/jkms.2005.20.6.1053.

Natural Menopause and Risk of Stroke in Elderly Women

• Choi SH
• Lee SM
• Kim Y
• Choi NK
• Cho YJ
• Park BJ

• KMID: 2157761
• DOI: http://doi.org/10.3346/jkms.2005.20.6.1053

Abstract

Although early natural menopause has been postulated to increase stroke risk, studies have not produced convincing results. We examined the associations between stroke risks and age at natural menopause or time since natural menopause. 5,731 naturally postmenopausal women more than 65 yr of age were followed from 1993 to 1998. Information on age at menopause and risk factors were obtained using mailed questionnaires. 186 cases of stroke occurred over a total 27,936 person years. After adjusting for age, hypertension, and physical activity, age at menopause was not found to be significantly associated with stroke or cerebral infarction. However, adjusted relative risks (aRRs) showed a significant increasing tendency of hemorrhagic stroke versus age at menopause (aRRs, 0.66, 0.48, 1.00 and 2.33 for the following age groups at menopause; 40-44, 45-49, 50-54 [reference group], and > or =55 yr). Time since menopause (11-20, 21-30, and > or =31 yr) was not found to be significantly associated with cerebral infarction, or hemorrhagic stroke. Late menopause (menopause age > or =55 yr) showed a tendency of a lower risk of cerebral infarction (aRR, 0.79) and a higher risk of hemorrhagic stroke (aRR, 2.33). Further study is warranted to determine stroke risk in women during the decade following menopause.

Keyword

Menopause; Stroke; Cerebrovascular Accident; Aged; Women; Cohort Studies

MeSH Terms

Adult
Age Factors
Aged
Aged, 80 and over
Cerebral Hemorrhage/etiology
Cerebral Infarction/etiology
Cerebrovascular Accident/*etiology
Cohort Studies
Female
Humans
Korea
*Menopause
Middle Aged
Prospective Studies
Questionnaires
Research Support, Non-U.S. Gov't
Time Factors

Reference

1. Dyken ML, Wolf PA, Barnett HJM, Bergan JJ, Hass WK, Kannel WB, Kuller L, Kurtzke JF, Sundt TM. Risk factors in stroke. A statement for physicians by the Subcommittee on risk factors and stroke of the Stroke Council. Stroke. 1984. 15:1105–1111.

2. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease. The Framingham study. Ann Intern Med. 1976. 85:447–452.

3. Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease. The Framingham Study. Ann Intern Med. 1978. 89:157–161.

4. Parrish HM, Carr CA, Hall DG, King TM. Time interval from castration in premenopausal women to development of excessive coronary atherosclerosis. Am J Obstet Gynecol. 1967. 99:155–162.

5. Robinson RW, Higano N, Cohen WD. Increased incidence of coronary heart disease in women castrated prior to the menopause. Arch Int Med. 1959. 104:908–913.

6. Hu FB, Grodstein F, Hennekens CH, Colditz GA, Johnson M, Manson JE, Rosner B, Stampfer MJ. Age at natural menopause and risk of cardiovascular disease. Arch Intern Med. 1999. 159:1061–1066.

7. Snowdon DA, Kane RL, Beeson WL, Burke GL, Sprafka JM, Potter J, Iso H, Jacobs DR Jr, Phillips RL. Is early natural menopause a biologic marker of health and aging? Am J Public Health. 1989. 79:709–714.

8. Cooper GS, Sandler DP. Age at natural menopause and mortality. Ann Epidemiol. 1988. 8:229–235.

9. van der Schouw YT, van der Graaf Y, Steyerberg EW, Eijkemans MJC, Banga JD. Age at menopause as a risk factor for cardiovascular mortality. Lancet. 1996. 347:714–718.

10. Joakimsen O, Bønaa KH, Stensland-Bugge E, Jacobsen BK. Population-based study of age at menopause and ultrasound assessed carotid atherosclerosis. The Tromsø study. J Clin Epidemiol. 2000. 53:525–530.

11. Vermeulen A, Verdonck L. Sex hormone concentrations in post-menopausal women. Relation to obesity, fat mass, age and years post-menopause. Clin Endocrinol. 1978. 9:59–66.

12. Kagan A, Popper JS, Rhoads GG. Factors related to stroke incidence in Hawaii Japanese men. The Honolulu Heart Study. Stroke. 1980. 11:14–21.

13. Worth RM, Kato H, Rhoads GG, Kagan A, Syme SL. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: mortality. Am J Epidemiol. 1975. 102:481–490.

14. Park BJ, Cho YK, Kim SA. Construction of the Korea Elderly Pharmacoepidemiologic Cohort: drug utilization review of cephalosporins in geriatric inpatients. Pharmacoepidemiol Drug Saf. 2001. 10:487–492.

15. Park BJ, Kim DS, Koo HW, Bae JM. Reliability and validity study of a life style questionnaire for elderly people. Korean J Prev Med. 1998. 31:49–58.

16. The World Health Organization. MONICA Project (monitoring of trends and determinants in cardiovascular disease): a major international collaboration. WHO Monica Project principal investigators. J Clin Epidemiol. 1988. 41:105–114.

17. Jacobsen BK, Heuch I, Kvåle G. Age at natural menopause and all-cause mortality: a 37-year follow-up of 19,731 Norwegian women. Am J Epidemiol. 2003. 157:923–929.

18. Ackerman RF, Dry TJ, Edwards JE. Relationship of various factors to the degree of coronary atherosclerosis in women. Circulation. 1950. 1:1345–1354.

19. Dobs AS, Nieto FJ, Szklo M, Barnes R, Sharrett AR, Ko WJ. Risk factors for popliteal and carotid wall thicknesses in the atherosclerosis risk in communities (ARIC) study. Am J Epidemiol. 1999. 150:1055–1067.

20. Jacobsen BK, Heuch I, Kvale G. Age at natural menopause and stroke mortality: cohort study with 3561 stroke deaths during 37-year follow-up. Stroke. 2004. 35:1548–1551.

21. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 1998. 280:605–613.

22. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, Wenger N. Cardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and Estrogen/Progestin Replacement Study follow-up (HERS II). JAMA. 2002. 288:49–57.

23. Bath PM, Gray LJ. Association between hormone replacement therapy and subsequent stroke: a meta-analysis. BMJ. 2005. 330:342.

24. Im JA, Kim SH, Lee DC. Effects of Long term hormone therapy on platelet activation in postmenopausal women. J Korean Acad Fam Med. 2004. 25:754–759.

25. Park JK, Kim HJ, Chang SJ, Koh SB, Koh SY. Risk factors for hemorrhagic stroke in Wonju, Korea. Yonsei Med J. 1998. 39:229–235.